These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 33585946)
21. Variegate porphyria. Mustajoki P Ann Intern Med; 1978 Aug; 89(2):238-44. PubMed ID: 677592 [TBL] [Abstract][Full Text] [Related]
22. [Oxidative stress in porphyria and carriers]. Aminaka M; Kondo M; Takata A; Yamauchi H; Ikeda M; Yoshida K Nihon Eiseigaku Zasshi; 2008 May; 63(3):628-35. PubMed ID: 18567368 [TBL] [Abstract][Full Text] [Related]
23. Modern diagnosis and management of the porphyrias. Sassa S Br J Haematol; 2006 Nov; 135(3):281-92. PubMed ID: 16956347 [TBL] [Abstract][Full Text] [Related]
24. [APROPOS OF A CASE OF WATSON'S MIXED PORPHYRIA]. HURIEZ C; AGACHE P; PETIT H; FOURLINNIE JC Bull Soc Fr Dermatol Syphiligr; 1964; 71():35-8. PubMed ID: 14184733 [No Abstract] [Full Text] [Related]
25. Clinical Guide and Update on Porphyrias. Stölzel U; Doss MO; Schuppan D Gastroenterology; 2019 Aug; 157(2):365-381.e4. PubMed ID: 31085196 [TBL] [Abstract][Full Text] [Related]
27. Clinical indications for the investigation of porphyria: case examples and evolving laboratory approaches to its diagnosis in New Zealand. Sies C; Florkowski C; George P; Potter H N Z Med J; 2005 Sep; 118(1222):U1658. PubMed ID: 16222352 [TBL] [Abstract][Full Text] [Related]
30. Variegate porphyria in a 46-year-old patient taking sibutramine for weight loss. Reiser M; Eickmann S; Haverkamp T; Finckh U Obes Rev; 2010 Apr; 11(4):329-31. PubMed ID: 19845869 [TBL] [Abstract][Full Text] [Related]
31. Biallelic inactivation of protoporphyrinogen oxidase and hydroxymethylbilane synthase is associated with liver cancer in acute porphyrias. Schneider-Yin X; van Tuyll van Serooskerken AM; Siegesmund M; Went P; Barman-Aksözen J; Bladergroen RS; Komminoth P; Cloots RH; Winnepenninckx VJ; zur Hausen A; Weber M; Driessen A; Poblete-Gutiérrez P; Bauer P; Schroeder C; van Geel M; Minder EI; Frank J J Hepatol; 2015 Mar; 62(3):734-8. PubMed ID: 25445397 [TBL] [Abstract][Full Text] [Related]
33. Enzyme antioxidant defences and oxidative damage in red blood cells of variegate porphyria patients. Ferrer MD; Tauler P; Sureda A; Romaguera D; Llompart I; Palacin C; Orfila J; Tur JA; Pons A Redox Rep; 2009; 14(2):69-74. PubMed ID: 19389274 [TBL] [Abstract][Full Text] [Related]
34. Liver transplantation in the management of porphyria. Singal AK; Parker C; Bowden C; Thapar M; Liu L; McGuire BM Hepatology; 2014 Sep; 60(3):1082-9. PubMed ID: 24700519 [TBL] [Abstract][Full Text] [Related]
35. A review of the clinical presentation, natural history and inheritance of variegate porphyria: its implausibility as the source of the 'Royal Malady'. Hift RJ; Peters TJ; Meissner PN J Clin Pathol; 2012 Mar; 65(3):200-5. PubMed ID: 22049218 [TBL] [Abstract][Full Text] [Related]
36. Clinically important features of porphyrin and heme metabolism and the porphyrias. Besur S; Hou W; Schmeltzer P; Bonkovsky HL Metabolites; 2014 Nov; 4(4):977-1006. PubMed ID: 25372274 [TBL] [Abstract][Full Text] [Related]
37. Bile porphyrin analysis in the evaluation of variegate porphyria. Logan GM; Weimer MK; Ellefson M; Pierach CA; Bloomer JR N Engl J Med; 1991 May; 324(20):1408-11. PubMed ID: 2020296 [TBL] [Abstract][Full Text] [Related]
39. A mouse model for South African (R59W) variegate porphyria: construction and initial characterization. Medlock AE; Meissner PN; Davidson BP; Corrigall AV; Dailey HA Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):71-8. PubMed ID: 11929050 [TBL] [Abstract][Full Text] [Related]
40. Porphyrias amongst patients with cutaneous photosensitivity in Kashmir: a seven year experience. Majid S; Ahmad QM; Shah IH Indian J Dermatol Venereol Leprol; 2012; 78(4):520. PubMed ID: 22772637 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]